Acumen Pharmaceuticals
ABOS
ABOS
73 hedge funds and large institutions have $108M invested in Acumen Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
10% less funds holding
Funds holding: 81 → 73 (-8)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
90% less call options, than puts
Call options by funds: $226K | Put options by funds: $2.19M
Holders
73
Holding in Top 10
1
Calls
$226K
Puts
$2.19M
Top Buyers
| 1 | +$592K | |
| 2 | +$429K | |
| 3 | +$426K | |
| 4 |
Morgan Stanley
New York
|
+$375K |
| 5 |
Goldman Sachs
New York
|
+$235K |
Top Sellers
| 1 | -$772K | |
| 2 | -$488K | |
| 3 | -$296K | |
| 4 |
Man Group
London,
United Kingdom
|
-$256K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$178K |